Briacell Therapeutics Corp (BCTX)

$3.37 +0.01 (0.30%)
Market Cap 29.23M
Revenue (ttm) 0.00
Net Income (ttm) -26.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 143,900
Avg Vol 171,420
Day's Range N/A - N/A
Shares Out 8.70M
Stochastic %K 19%
Beta 1.14
Analysts Strong Buy
Price Target $40.00

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 921 1810
Fax: 604 921 1898
Address:
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
Goodstockday
Goodstockday Aug. 5 at 1:32 PM
$BCTX New company slogan: “BriaCell - We save both breasts and balls!”
0 · Reply
BCTX20bMC
BCTX20bMC Aug. 5 at 1:26 PM
$BCTX The cry babies are broken records during the week…Dilution & RS is all they have…Then they fill out their signs & protest on weekends.
1 · Reply
Merlintrader
Merlintrader Aug. 5 at 1:22 PM
$BCTX FDA clears the Bria-PROS+ IND, allowing a Phase 1/2a prostate-cancer study to begin https://www.merlintrader.com/briacell-therapeutics-stock-hub/
0 · Reply
MikeTechnician
MikeTechnician Aug. 5 at 1:16 PM
FDA says "Study May Proceed" for BriaCell's Bria-PROS+ prostate cancer program. Clinical testing is next. $BCTX Regulatory milestone ✅ News: https://bit.ly/4pX8Grz #Biotech #CancerImmunotherapy #ProstateCancer #HealthcareStocks
0 · Reply
BCTX20bMC
BCTX20bMC Aug. 5 at 1:15 PM
$BCTX again…and again…and again….for the thick skulls with pea brains. They have enough $ to get them to the p3 readout. After the positive p3 news they will then prob raise more funds when the SP is 25+…Patience.
1 · Reply
ProfessorDman1
ProfessorDman1 Aug. 5 at 12:46 PM
$BCTX news out and not sure why it’s not $5+ yet 🧐 I bought some herd mid 3s $AMIX went crazy yesterday $YXT going now $CISS still strong 💪🏾 $DBGI 💪🏾
0 · Reply
Kirubin
Kirubin Aug. 5 at 12:40 PM
$BCTX Where do you think the money will come from🥶🥶 ! offering machine. Expect plenty more coming your way!
1 · Reply
prismmarketview
prismmarketview Aug. 5 at 12:37 PM
$BCTX FDA clearance is in for BriaCell’s Bria-PROS prostate cancer study, clearing the way for clinical evaluation of its cell-based immunotherapy candidate. https://prismmarketview.com/briacell-gets-fda-clearance-to-launch-bria-pros-study-in-prostate-cancer/
0 · Reply
BioTerror
BioTerror Aug. 5 at 12:16 PM
$BCTX when news drops on a low float and no ones paying attention. I'm loading... expecting a delayed reaction here ⏳💣
0 · Reply
KJolive
KJolive Aug. 5 at 12:13 PM
$BCTX in for 5k shares
0 · Reply
Latest News on BCTX
BriaCell gets FDA clearance for Bria-PROS+ study in prostate cancer

2026-08-05T13:46:04.000Z - 23 minutes ago

BriaCell gets FDA clearance for Bria-PROS+ study in prostate cancer

BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer

Wed, 05 Aug 2026 07:30:00 -0400 - 2 hours ago

BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer

BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site

2026-07-16T13:27:49.000Z - 20 days ago

BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site

BriaCell announces Odette Cancer Centre joins Bria-IMT trial

2026-07-16T11:40:48.000Z - 20 days ago

BriaCell announces Odette Cancer Centre joins Bria-IMT trial

BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer

Thu, 16 Jul 2026 07:30:00 -0400 - 20 days ago

BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer

BriaCell (BCTX) Partners with Fujifilm for Cell Therapy Manufacturing

2026-07-15T13:32:56.000Z - 21 days ago

BriaCell (BCTX) Partners with Fujifilm for Cell Therapy Manufacturing

BriaCell arranges scalable manufacturing with Fujifilm Biotechnologies

2026-07-15T12:10:22.000Z - 21 days ago

BriaCell arranges scalable manufacturing with Fujifilm Biotechnologies

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™

Wed, 15 Jul 2026 07:30:00 -0400 - 21 days ago

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™

Tue, 07 Jul 2026 07:30:00 -0400 - 4 weeks ago

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™

BriaCell Partners With Uneedle To Support Scalable Microneedle Delivery Of Bria-IMT

2026-06-26T10:06:07.000Z - 5 weeks ago

BriaCell Partners With Uneedle To Support Scalable Microneedle Delivery Of Bria-IMT

BriaCell (BCTX) Partners with Uneedle for Microneedle Technology Development

2026-06-25T13:25:58.000Z - 5 weeks ago

BriaCell (BCTX) Partners with Uneedle for Microneedle Technology Development

BriaCell enters MoU with Uneedle for microneedle technology

2026-06-25T11:45:30.000Z - 5 weeks ago

BriaCell enters MoU with Uneedle for microneedle technology

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™

Thu, 25 Jun 2026 07:30:00 -0400 - 5 weeks ago

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™

BriaCell Therapeutics Announces Closing of Offering

Tue, 02 Jun 2026 16:05:00 -0400 - 2 months ago

BriaCell Therapeutics Announces Closing of Offering

BriaCell Presents Positive Clinical Data at ASCO 2026

Mon, 01 Jun 2026 07:30:00 -0400 - 2 months ago

BriaCell Presents Positive Clinical Data at ASCO 2026

BriaCell Therapeutics Announces Pricing of Offering

Sun, 31 May 2026 19:59:00 -0400 - 2 months ago

BriaCell Therapeutics Announces Pricing of Offering

BriaCell (BCTX) Receives Positive Update from Data Safety Monitoring Board

2026-05-26T14:43:01.000Z - 2 months ago

BriaCell (BCTX) Receives Positive Update from Data Safety Monitoring Board

BriaCell receives recommendation for DSMB for Phase 3 Bria-ABC study

2026-05-26T13:05:39.000Z - 2 months ago

BriaCell receives recommendation for DSMB for Phase 3 Bria-ABC study

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

Tue, 26 May 2026 07:30:00 -0400 - 2 months ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

BriaCell (BCTX) Unveils Key Clinical Data at ASCO Annual Meeting 2026

2026-05-22T13:27:19.000Z - 2 months ago

BriaCell (BCTX) Unveils Key Clinical Data at ASCO Annual Meeting 2026

BriaCell announces data from Bria-IMT at ASCO 2026

2026-05-22T11:49:02.000Z - 2 months ago

BriaCell announces data from Bria-IMT at ASCO 2026

BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026

Fri, 22 May 2026 07:30:00 -0400 - 2 months ago

BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™

Fri, 15 May 2026 07:30:00 -0400 - 2 months ago

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™

BriaCell (BCTX) Completes Manufacturing for New Prostate Cancer Treatment

2026-05-14T15:31:53.000Z - 2 months ago

BriaCell (BCTX) Completes Manufacturing for New Prostate Cancer Treatment

BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer

Thu, 14 May 2026 07:30:00 -0400 - 2 months ago

BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer

BriaCell (BCTX) Expands Clinical Trial Network for Advanced Breast Cancer Treatment

2026-05-13T16:39:28.000Z - 2 months ago

BriaCell (BCTX) Expands Clinical Trial Network for Advanced Breast Cancer Treatment

BriaCell adds Penn Medicine as Phase 3 breast cancer study site

2026-05-13T14:41:55.000Z - 2 months ago

BriaCell adds Penn Medicine as Phase 3 breast cancer study site

BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Wed, 13 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Tue, 12 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Thu, 07 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

BriaCell receives FDA clearance to initiate Bria-BRES+ trial

2026-05-07T04:03:56.000Z - 3 months ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial

BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer

Wed, 06 May 2026 07:30:00 -0400 - 3 months ago

BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer

BriaCell Announces Six Clinical Data Presentations at ASCO 2026

Mon, 27 Apr 2026 07:30:00 -0400 - 3 months ago

BriaCell Announces Six Clinical Data Presentations at ASCO 2026

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

2026-04-21T13:28:43.000Z - 3 months ago

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

BriaCell presents anti-cancer activity of Bria-OTS

2026-04-21T11:54:23.000Z - 3 months ago

BriaCell presents anti-cancer activity of Bria-OTS

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models

Tue, 21 Apr 2026 07:30:00 -0400 - 3 months ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models

BriaCell (BCTX) Showcases Positive Clinical Data at AACR Annual Meeting

2026-04-20T13:32:04.000Z - 3 months ago

BriaCell (BCTX) Showcases Positive Clinical Data at AACR Annual Meeting

BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR

2026-04-20T11:41:56.000Z - 3 months ago

BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR

BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

Mon, 20 Apr 2026 07:30:00 -0400 - 3 months ago

BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

Tue, 31 Mar 2026 16:05:00 -0400 - 4 months ago

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeting

2026-03-18T13:30:56.000Z - 5 months ago

BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeting

BriaCell to present four posters at the 2026 AACR

2026-03-18T11:42:55.000Z - 5 months ago

BriaCell to present four posters at the 2026 AACR

BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference

Wed, 18 Mar 2026 07:30:00 -0400 - 5 months ago

BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference

BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting

Tue, 10 Mar 2026 07:30:00 -0400 - 5 months ago

BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Thu, 05 Mar 2026 16:04:00 -0500 - 5 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

BriaCell (BCTX) Expands Biologic Cancer Treatments Through New Agreement

2026-02-18T22:51:30.000Z - 5 months ago

BriaCell (BCTX) Expands Biologic Cancer Treatments Through New Agreement

BriaPro to purchase BriaCell’s license to develop, commercialize sCD80

2026-02-18T22:35:25.000Z - 5 months ago

BriaPro to purchase BriaCell’s license to develop, commercialize sCD80

BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

Wed, 18 Feb 2026 17:30:00 -0500 - 5 months ago

BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

BriaCell receives positive recommendation from DSMB for Phase 3 Bria-ABC study

2026-02-17T12:40:59.000Z - 6 months ago

BriaCell receives positive recommendation from DSMB for Phase 3 Bria-ABC study

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

Tue, 17 Feb 2026 07:30:00 -0500 - 6 months ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

Goodstockday
Goodstockday Aug. 5 at 1:32 PM
$BCTX New company slogan: “BriaCell - We save both breasts and balls!”
0 · Reply
BCTX20bMC
BCTX20bMC Aug. 5 at 1:26 PM
$BCTX The cry babies are broken records during the week…Dilution & RS is all they have…Then they fill out their signs & protest on weekends.
1 · Reply
Merlintrader
Merlintrader Aug. 5 at 1:22 PM
$BCTX FDA clears the Bria-PROS+ IND, allowing a Phase 1/2a prostate-cancer study to begin https://www.merlintrader.com/briacell-therapeutics-stock-hub/
0 · Reply
MikeTechnician
MikeTechnician Aug. 5 at 1:16 PM
FDA says "Study May Proceed" for BriaCell's Bria-PROS+ prostate cancer program. Clinical testing is next. $BCTX Regulatory milestone ✅ News: https://bit.ly/4pX8Grz #Biotech #CancerImmunotherapy #ProstateCancer #HealthcareStocks
0 · Reply
BCTX20bMC
BCTX20bMC Aug. 5 at 1:15 PM
$BCTX again…and again…and again….for the thick skulls with pea brains. They have enough $ to get them to the p3 readout. After the positive p3 news they will then prob raise more funds when the SP is 25+…Patience.
1 · Reply
ProfessorDman1
ProfessorDman1 Aug. 5 at 12:46 PM
$BCTX news out and not sure why it’s not $5+ yet 🧐 I bought some herd mid 3s $AMIX went crazy yesterday $YXT going now $CISS still strong 💪🏾 $DBGI 💪🏾
0 · Reply
Kirubin
Kirubin Aug. 5 at 12:40 PM
$BCTX Where do you think the money will come from🥶🥶 ! offering machine. Expect plenty more coming your way!
1 · Reply
prismmarketview
prismmarketview Aug. 5 at 12:37 PM
$BCTX FDA clearance is in for BriaCell’s Bria-PROS prostate cancer study, clearing the way for clinical evaluation of its cell-based immunotherapy candidate. https://prismmarketview.com/briacell-gets-fda-clearance-to-launch-bria-pros-study-in-prostate-cancer/
0 · Reply
BioTerror
BioTerror Aug. 5 at 12:16 PM
$BCTX when news drops on a low float and no ones paying attention. I'm loading... expecting a delayed reaction here ⏳💣
0 · Reply
KJolive
KJolive Aug. 5 at 12:13 PM
$BCTX in for 5k shares
0 · Reply
Biohero
Biohero Aug. 5 at 12:02 PM
$BCTX premarket High 3,86$
0 · Reply
ISmokeCigs
ISmokeCigs Aug. 5 at 11:53 AM
$BCTX well this is going no where lmao
1 · Reply
Dryrr
Dryrr Aug. 5 at 11:48 AM
$BCTX they dont have the money for this though. so offering on this news is to be expected right?
1 · Reply
Makessense
Makessense Aug. 5 at 11:47 AM
$BCTX offering News?
0 · Reply
GuyFawkes_EOD
GuyFawkes_EOD Aug. 5 at 11:47 AM
$BCTX
0 · Reply
ISmokeCigs
ISmokeCigs Aug. 5 at 11:43 AM
$BCTX
0 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Aug. 5 at 11:41 AM
$BCTX soooo when’s the offering?
0 · Reply
ProfessorDman1
ProfessorDman1 Aug. 5 at 11:40 AM
$BCTX BriaCell Therapeutics Receives FDA Clearance To Proceed With Clinical Evaluation Of Bria-PROS+, Its Next-Gen Personalized Off-The-Shelf Immunotherapy For Prostate Cancer Can she run like $AMIX ? AMIX did 500% almost yesterday with news BCTX news just dropped ☝️
0 · Reply
STACKD0E
STACKD0E Aug. 5 at 11:38 AM
$BCTX $MOB $SDST 👁
0 · Reply
SmallCapVoice
SmallCapVoice Aug. 5 at 11:37 AM
Stock to watch: $BCTX BriaCell is a stock to watch after FDA clearance to begin its Bria-PROS+ clinical study in prostate cancer. https://www.globenewswire.com/news-release/2026/08/05/3339216/0/en/briacell-receives-fda-clearance-to-initiate-bria-pros-clinical-study-in-prostate-cancer.html Keep $BCTX on your watchlist.
0 · Reply
Biohero
Biohero Aug. 5 at 11:37 AM
$BCTX huge news, let's go! 4$ EOW? https://www.globenewswire.com/news-release/2026/08/05/3339216/0/en/briacell-receives-fda-clearance-to-initiate-bria-pros-clinical-study-in-prostate-cancer.html
0 · Reply
Stock_Catcher
Stock_Catcher Aug. 5 at 11:31 AM
$BCTX BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer
0 · Reply